TITLE:
      Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
SUMMARY:
      The purpose of this study is to assess the abuse liability and reinforcing effects of
      intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent
      volunteers
DETAILED DESCRIPTION:
      not available at this time
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        Individuals must be at least 18 yrs of age, currently opioid dependent and must not be
        seeking treatment. Co-morbid substance abuse or dependence disorders may also be present.
        Individuals must be healthy despite drug dependency and have a history of IV opioid use.

        Exclusion Criteria:

        Individuals with evidence of an active Diagnostic and Statistical Manual of Mental
        Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness,
        organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular
        disease) or pregnant female subjects are excluded from study participation.
